Clinical Trial Update: Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating influenza vaccination to prevent cardiovascular events after acute coronary syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED